Weiss Multi Strategy Advisers LLC Nektar Therapeutics Transaction History

Weiss Multi Strategy Advisers LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $152,697 - $284,269	-5,018 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $231,463 - $341,217	-4,982 Reduced 49.82%	5,018 $306,000
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $231,250 - $522,250	5,000 Added 100.0%	10,000 $488,000
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $287,000 - $542,200	5,000 New	5,000 $531,000

146

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $189M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.